» Articles » PMID: 33227987

Availability of Guanitoxin in Water Samples Containing Cells Submitted to Dissolution Tests

Overview
Publisher MDPI
Specialty Chemistry
Date 2020 Nov 24
PMID 33227987
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Guanitoxin (GNT) is a potent neurotoxin produced by freshwater cyanobacteria that can cause the deaths of wild and domestic animals. Through reports of animal intoxication by cyanobacteria cells that produce GNT, this study aimed to investigate the bio-accessibility of GNT in simulated solutions of the gastrointestinal content in order to understand the process of toxicosis promoted by GNT in vivo. Dissolution tests were conducted with a mixture of (Cyanobacteria; Nostocales) cultures (30%) and gastrointestinal solutions with and without proteolytic enzymes (70%) at a temperature of 37 °C and rotation at 100 rpm for 2 h. The identification of GNT was performed by LC-QqQ-MS/MS through the transitions [M + H] 253 > 58 and [M + H] 253 > 159, which showed high concentrations of GNT in simulated gastric fluid solutions (-value < 0.001) in comparison to simulated solutions of intestinal content. The gastric solution with pepsin promoted the stability of GNT (-value < 0.05) compared to the simulated solution of gastric fluid at the same pH without the enzyme. However, the results showed that GNT is also available in intestinal fluids for a period of 2 h, and solutions containing the pancreatin enzyme influenced the bio-accessibility of the toxin more compared to the intestinal medium without enzyme (-value < 0.05). Therefore, the bio-accessibility of the toxin must be considered both in the stomach and in the intestine, and may help in the diagnosis and prediction of exposure and risk in vivo through the oral ingestion of GNT-producing cyanobacteria cells.

Citing Articles

Cyanotoxins, biosynthetic gene clusters, and factors modulating cyanotoxin biosynthesis.

Bashir F, Bashir A, Bouaicha N, Chen L, Codd G, Neilan B World J Microbiol Biotechnol. 2023; 39(9):241.

PMID: 37394567 DOI: 10.1007/s11274-023-03652-x.


Cyanotoxins and the Nervous System.

Metcalf J, Tischbein M, Cox P, Stommel E Toxins (Basel). 2021; 13(9).

PMID: 34564664 PMC: 8472772. DOI: 10.3390/toxins13090660.

References
1.
Fiore M, de Lima S, Carmichael W, McKinnie S, Chekan J, Moore B . Guanitoxin, re-naming a cyanobacterial organophosphate toxin. Harmful Algae. 2020; 92:101737. DOI: 10.1016/j.hal.2019.101737. View

2.
Singh R, Tiwari S, Rai A, Mohapatra T . Cyanobacteria: an emerging source for drug discovery. J Antibiot (Tokyo). 2011; 64(6):401-12. DOI: 10.1038/ja.2011.21. View

3.
Devic E, Li D, Dauta A, Henriksen P, Codd G, Marty J . Detection of anatoxin-a(s) in environmental samples of cyanobacteria by using a biosensor with engineered acetylcholinesterases. Appl Environ Microbiol. 2002; 68(8):4102-6. PMC: 123992. DOI: 10.1128/AEM.68.8.4102-4106.2002. View

4.
Monserrat J, Yunes J, Bianchini A . Effects of Anabaena spiroides (Cyanobacteria) aqueous extracts on the acetylcholinesterase activity of aquatic species. Environ Toxicol Chem. 2001; 20(6):1228-35. DOI: 10.1897/1551-5028(2001)020<1228:eoasca>2.0.co;2. View

5.
Klein S . The use of biorelevant dissolution media to forecast the in vivo performance of a drug. AAPS J. 2010; 12(3):397-406. PMC: 2895438. DOI: 10.1208/s12248-010-9203-3. View